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Summary
Several age-related traits are associated with shorter
telomeres, the structures that cap the end of linear chro-
mosomes. A common polymorphism near the telomere
maintenance gene TERT has been associated with sev-
eral cancers, but relationships with other aging traits
such as physical capability have not been reported. As
part of the Healthy Ageing across the Life Course (HAL-
Cyon) collaborative research programme, men and
women aged between 44 and 90 years from nine UK
cohorts were genotyped for the single-nucleotide poly-
morphism (SNP) rs401681. We then investigated relation-
ships between the SNP and 30 age-related phenotypes,
including cognitive and physical capability, blood lipid
levels and lung function, pooling within-study genotypic
effects in meta-analyses. No significant associations
were found between the SNP and any of the cognitive
performance tests (e.g. pooled beta per T allele for word
recall z-score = 0.02, 95% CI: )0.01 to 0.04, P-value =
0.12, n = 18 737), physical performance tests (e.g. pooled
beta for grip strength = )0.02, 95% CI: )0.045 to 0.006,
P-value = 0.14, n = 11 711), blood pressure, lung function
or blood test measures. Similarly, no differences in
observations were found when considering follow-up
measures of cognitive or physical performance after
adjusting for its measure at an earlier assessment. The
lack of associations between SNP rs401681 and a wide
range of age-related phenotypes investigated in this large
multicohort study suggests that while this SNP may be
associated with cancer, it is not an important contributor
to other markers of aging.
Key words: aging; cognition; middle-aged; physical;
telomere.
Introduction
Aging is caused by the accumulation of molecular and cellular
damage over time resulting in frailty and disease (Kirkwood,
2008). One likely source is from damage to DNA reflected in
telomere shortening (Chan & Blackburn, 2004; Kirkwood,
2008). Telomeres are formed from a repetitive DNA sequence
(TTAGGG 5¢ to 3¢) and a variety of proteins, and are located on
the end of linear chromosomes. They protect against the loss of
genetic material during cell division (Calado & Young, 2009).
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Human telomerase is an enzyme composed of two protein com-
ponents: telomerase reverse transcriptase (encoded by the TERT
gene) and dyskerin (encoded by DKC1), and a RNA component
(encoded by TERC) that elongates telomeres by adding the
telomeric repeats to the chromosome ends (Blasco, 2005; Co-
hen et al., 2007; Calado & Young, 2009). However, owing to
low telomerase activity in most normal human somatic cells
(Blasco, 2005), telomeres undergo attrition with losses in the
range of 20–70 bp per year estimated in adults (Benetos et al.,
2001; Canela et al., 2007; Codd et al., 2010). Shorter telomere
length has been associated with several age-related conditions
(Aviv, 2006), such as hypertension (Huda et al., 2007), coronary
heart disease (Brouilette et al., 2007), dementia (Martin-Ruiz
et al., 2006), premature aging syndromes (Blasco, 2005) and
mortality (Bakaysa et al., 2007). Although it remains unclear
whether telomere shortening is a cause or simply a consequence
of aging (Calado & Young, 2009), these associations have led to
the widespread notion that telomere shortening represents a
mechanism for aging in general.
While it has been suggested that oxidative stress and inflamma-
tion are contributors to telomere loss (von Zglinicki, 2002; Valdes
et al., 2005; Ornish et al., 2008; Starr et al., 2008), telomere
length is highly heritable with family studies providing estimates
between 35% and 80% (Slagboom et al., 1994; Bischoff et al.,
2005; Vasa-Nicotera et al., 2005; Bakaysa et al., 2007). As a
putative polygenic trait, several loci have been implicated (Vasa-
Nicotera et al., 2005; Andrew et al., 2006; Mangino et al., 2008,
2009; Starr et al., 2008; Levy et al., 2010), with some including
genes known to be directly involved in telomere maintenance in
humans (Codd et al., 2010). In addition to telomerase activity
(Ludlow et al., 2008) and telomere length (Matsubara et al.,
2006a,b), single-nucleotide polymorphisms (SNPs) located in the
TERT-CLPTM1L locus have been associated with exceptional lon-
gevity (Atzmon et al., 2010), coronary artery disease (Matsubara
et al., 2006a), idiopathic pulmonary fibrosis (Mushiroda et al.,
2008), glioma (Shete et al., 2009), red blood cell count (Kamatani
et al., 2010), survival in patients with lung cancer (Catarino et al.,
2010) and several cancers (Ruiz-Llorente et al., 2007; McKay
et al., 2008; Andrew et al., 2009; Broderick et al., 2009; Choi
et al., 2009; Hosgood et al., 2009; Landi et al., 2009; Van Dyke
et al., 2009; Zienolddiny et al., 2009; Hsiung et al., 2010; John-
atty et al., 2010; Prescott et al., 2010; Shen et al., 2010; Turnbull
et al., 2010; Wang et al., 2010). Specifically, relationships have
been reported between the C allele of a common, intronic poly-
morphism in CLPTM1L (rs401681) and shorter telomere length in
elderly females (Rafnar et al., 2009), increased PSA levels
(Gudmundsson et al., 2010), increased basal cell carcinoma (Raf-
nar et al., 2009; Stacey et al., 2009), prostate (Rafnar et al.,
2009), cervical (Rafnar et al., 2009), bladder (Rothman et al.,
2010) and lung (Wang et al., 2008; Rafnar et al., 2009; Kohno
et al., 2010; Miki et al., 2010) cancer risk and a reduced risk of
melanoma (Stacey et al., 2009) and pancreatic (Petersen et al.,
2010) cancer, although there is a lack of association with breast
cancer (Rafnar et al., 2009; Pooley et al., 2010). Over-expression
of CLPTM1L (cisplatinum resistance related protein) has been
associated with apoptosis (Yamamoto et al., 2001). It should be
noted that cancer incidence increases steeply with age (Nordling,
1953; DePinho, 2000; Cancer Research UK, 2010).
We therefore hypothesized that polymorphisms in the TERT-
CLPTM1L locus could be related to other age-related pheno-
types, such as lower physical and cognitive capability, traits that
are known to have a genetic component (McClearn et al., 1997;
Tiainen et al., 2004; Volk et al., 2006; Matteini et al., 2010). To
investigate this, we analysed data from 25 774 participants
aged between 44 and 90 from nine UK cohorts as part of the
Healthy Ageing across the Life Course (HALCyon; http://
www.halcyon.ac.uk/) collaborative research programme. The
HALCyon programme aims to understand three components of
healthy aging: (i) physical and cognitive capability; (ii) psycholog-
ical and social wellbeing; and (iii) the underlying biology. The
well-established cohorts are all appropriate for investigating our
hypothesis, as all studies measured markers of physical or cogni-
tive capability or biological functioning in older adults. In this
exploratory study, we genotyped participants for the SNP
rs401681 and conducted analyses within the cohorts as well as
meta-analyses to assess associations between genotype and 30
Table 1 Summary of sex, age and genotype frequencies by cohort
Cohort Male (%) Age* in years, median (range)
C ⁄ C
n (%)
C ⁄ T
n (%)
T ⁄ T
n (%) Total (n)
Boyd Orr 46 70 (64 to 82) 227 (32.7) 341 (49.1) 127 (18.3) 695
CaPS 100 57 (47 to 67) 414 (29.9) 698 (50.5) 271 (19.6) 1383
ELSA 46 65 (52 to 90+) 1672 (30.7) 2709 (49.7) 1067 (19.6) 5448
HAS 61 67 (63 to 73) 159 (30.2) 267 (50.7) 101 (19.2) 527
HCS 53 66 (59 to 73) 905 (32.3) 1400 (49.9) 501 (17.9) 2806
LBC1921 42 79 (77 to 80) 178 (34.4) 249 (48.2) 90 (17.4) 517
NCDS 51 44 (44 to 45) 2317 (31.6) 3587 (49.0) 1417 (19.4) 7321
NSHD 50 53 780 (30.3) 1277 (49.6) 519 (20.1) 2576
Whitehall II 76 59 (50 to 73) 1467 (32.6) 2200 (48.9) 834 (18.5) 4501
Total 57 56 (44 to 90+) 8119 (31.5) 12 728 (49.4) 4927 (19.1) 25 774
CaPS, Caerphilly Prospective Study; ELSA, English Longitudinal Study of Ageing; HAS, Hertfordshire Ageing Study; HCS, Hertfordshire Cohort Study; NCDS,
National Child Development Study; NSHD, National Survey of Health and Development.
*Age at phase from which the majority of variables are taken, i.e. Boyd Orr: III; CaPS: II; ELSA: II; HAS: I; HCS: I; LBC1921: I; NCDS: Biomedical Survey
(2002); NSHD: 1999 Collection; Whitehall II: VII.
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age-related phenotypes including word recall score, grip
strength, lung function and cardiometabolic biomarkers. We
believe this to be the first report of an investigation between a
SNP in this locus and such traits.
Results
Cohort summaries and genotyping quality
Successful genotyping for SNP rs401681 and relevant pheno-
types were available for a total of 25 774 adults aged between
44 and 90 years old (Table 1). The quality of the genotyping
was good and consistent across all nine studies, with similar fre-
quencies, call rates exceeding 97% and the HWE condition
being met (P-value ‡0.3).
Associations between genotype and phenotypes
Minor allele frequencies (MAF) were tabulated by sex, 5-year
age bands (Table S1 in Supporting Information), cigarette smok-
ing status and physical activity (data not shown) to identify pos-
sible confounders of genotype effect on the outcome variables;
no associations were observed with the MAF so such variables
were not included in the regression models.
Table 2 shows there was no evidence of any associations
between the genotype and any of the cognitive test scores in
the meta-analyses (all P-values >0.1). Results for the genotypic
associations were similar in the within-study analyses investigat-
ing cognition scores in later phases adjusting for score at an ear-
lier phase (data not shown). Significant heterogeneity between
subgroups was only observed for AH4 analysed by sex (Fig. S2b
in Supporting Information), which was mainly driven by White-
hall II (interaction P-value = 0.0027), although this observation
was not seen for any other phenotype.
Nogenotypic associationswereobserved for any of thephysical
capability measures in the meta-analyses (Table 3) (all P-values
>0.1). In addition, therewas no evidence of associationswith grip
strength in the follow-upphases adjusting for itsmeasure at apre-
vious phase.
Table 4 and Table S2 (Supporting Information) show no asso-
ciations with BMI, waist–hip ratio (WHR) or the measures of bio-
logical function on the pooled analyses (all P-values >0.06).
There were no associations between genotype and MI,
angina, diabetes or stroke on the pooled data (Table 5) (all P-val-
ues >0.1). There was some evidence of an association between
the T allele and lower MI risk in Whitehall II (P-value = 0.005),
although this was not seen in the other studies.
There was no evidence in English Longitudinal Study of Age-
ing (ELSA) that the effects of genotype differed in individuals
aged below 70 years compared with those aged at least
70 years (data not shown), except for glucose (interaction P-
value = 0.038), although the association was not significant in
either age group.
In only a small number of tests did the full genotype model
represent a significantly better fit than the per allele model: AH4
score in Hertfordshire Ageing Study (HAS), grip strength in
LBC1921, chair rises in ELSA, BMI in HAS and Hertfordshire
Cohort Study (HCS), SBP and triglycerides in NSHD, MI in Caer-
philly, total cholesterol in HCS and NCDS, and stroke in HCS.
Forest plots for the meta-analyses are available in the Supporting
Information.
Discussion
We investigated relationships between SNP rs401681 in the
TERT-CLPTM1L locus and 30 age-related phenotypes in nine UK
cohorts of 25 774 older adults. To our knowledge, this is the
first time that this SNP has been examined with age-related
traits such as physical and cognitive capability. No associations
were found between genotype and any of the investigated
traits on the pooled analyses, even before correcting for multi-
ple testing. Also, no relationship was observed between geno-
type and age group, and although 93% of participants in our
analysis were younger than 75 years, preventing an investiga-
tion into mortality, this is consistent with an observed lack of
association with longevity (Rafnar et al., 2009). These findings
suggest that this variant is not an important contributor to a
wide range of aging traits, despite being associated with sev-
eral cancers (Wang et al., 2008; Rafnar et al., 2009; Stacey
et al., 2009; Kohno et al., 2010; Miki et al., 2010; Petersen
et al., 2010).
The number of investigations into the relationships between
SNPs in the locus and cancer types is growing. The findings
from studies examining rs401681 have been particularly inter-
esting, with its C allele being related to an increased risk of
basal cell carcinoma [odds ratio (OR): 1.20, 95% CI: 1.13–1.27
(Stacey et al., 2009)], lung [OR: 1.15, 95% CI: 1.10–1.22 (Raf-
nar et al., 2009)], bladder [OR: 1.11, 95% CI: 1.07–1.16 (Roth-
man et al., 2010)], prostate [OR: 1.07, 95% CI: 1.03–1.11
(Rafnar et al., 2009)] and cervical [OR: 1.31, 95% CI: 1.03–1.32
(Rafnar et al., 2009)] cancer. However, the same allele appears
to protect against melanoma [OR: 0.86, 95% CI: 0.81–0.91
(Stacey et al., 2009)] and pancreatic cancer [OR (authors’ con-
version): 0.84, 95% CI: 0.79–0.90 (Petersen et al., 2010)].
Meanwhile, the evidence for an association with colorectal (Raf-
nar et al., 2009; Pooley et al., 2010) and endometrial (Rafnar
et al., 2009; Prescott et al., 2010) cancer has been mixed, and
there is strong evidence against any association with breast can-
cer (Rafnar et al., 2009; Pooley et al., 2010). A summary of
these associations is given in Table S3 (Supporting Information).
Various hypotheses about how variants in the locus may affect
cancer risk have been proposed (Baird, 2010).
While in our population-based cohorts there were only 1076
cancer cases spread across numerous different tumour types,
we had good statistical power to investigate associations with
several other age-related phenotypes. Sample size calculations
for the quantitative traits estimated that around 4500 individu-
als would be required to detect a beta coefficient of 0.06 z-score
units with 80% power at the 5% significance level. As an exam-
ple, such a difference would correspond to a difference in AH4
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score between the two homozygote groups of around 1.2
points, assuming a standard deviation of 10. For most of the
phenotypes we had sufficient power to detect differences as
small as this, allowing us to conclude that associations between
rs401681 and these traits are either very small or there are no
associations.
Given that the C allele is associated with an increased risk of
various common cancers and that the incidence of cancers gen-
Table 5 Health history by genotype and cohort
Variable Cohort
C ⁄ C
n (%)*
C ⁄ T
n (%)*
T ⁄ T
n (%)*
Total
n (%)* OR (95% CI)† P-value
Het
P-value
MI Boyd Orr 10 (4.4) 20 (5.9) 10 (7.9) 40 (5.8) 1.362 (0.866–2.142) 0.18 0.08
CaPS 60 (14.7) 126 (18.3) 33 (12.4) 219 (16.1) 0.953 (0.774–1.173) 0.65
ELSA 87 (5.2) 146 (5.4) 52 (4.9) 285 (5.2) 0.976 (0.823–1.157) 0.78
HAS 15 (9.7) 21 (8.0) 10 (10.2) 46 (8.9) 1.004 (0.648–1.555) 0.99
Whitehall II 52 (3.8) 48 (2.3) 15 (1.9) 115 (2.7) 0.673 (0.511–0.888) 0.0050
Pooled [224 ⁄ 3830] [361 ⁄ 6053] [120 ⁄ 2338] [705 ⁄ 12 221] 0.936 (0.782–1.119) 0.47
Angina Boyd Orr 26 (13.1) 34 (11.9) 10 (9.7) 70 (11.9) 0.857 (0.597–1.231) 0.40 0.78
CaPS 48 (20.6) 83 (21.1) 33 (21.2) 164 (20.9) 1.018 (0.796–1.303) 0.89
ELSA 160 (9.6) 237 (8.8) 94 (8.8) 491 (9.0) 0.950 (0.832–1.085) 0.45
HAS 21 (13.5) 27 (10.3) 15 (15.2) 63 (12.2) 1.036 (0.708–1.514) 0.86
Whitehall II 65 (4.7) 96 (4.6) 25 (3.2) 186 (4.4) 0.852 (0.689–1.054) 0.14
Pooled [320 ⁄ 3649] [477 ⁄ 5733] [177 ⁄ 2212] [974 ⁄ 11 594] 0.937 (0.852–1.031) 0.18
Diabetes Boyd Orr 12 (9.2) 17 (9.0) 10 (14.7) 39 (10.1) 1.286 (0.804–2.057) 0.29 0.88
CaPS 31 (13.4) 49 (12.3) 25 (16.0) 105 (13.4) 1.099 (0.818–1.475) 0.53
ELSA 129 (7.7) 186 (6.9) 80 (7.5) 395 (7.3) 0.973 (0.840–1.126) 0.71
HAS 15 (10.1) 22 (8.9) 9 (9.3) 46 (9.3) 0.946 (0.612–1.461) 0.80
HCS 60 (6.7) 79 (5.7) 33 (6.7) 172 (6.2) 0.974 (0.779–1.217) 0.81
LBC1921 8 (4.5) 13 (5.2) 3 (3.3) 24 (4.6) 0.921 (0.511–1.661) 0.78
NCDS 38 (1.7) 66 (1.9) 21 (1.5) 125 (1.8) 0.971 (0.755–1.249) 0.82
NSHD 28 (3.6) 34 (2.7) 13 (2.5) 75 (2.9) 0.812 (0.583–1.131) 0.22
Whitehall II 100 (6.8) 126 (5.7) 49 (5.9) 275 (6.1) 0.907 (0.761–1.081) 0.27
Pooled [421 ⁄ 7750] [592 ⁄ 12 127] [243 ⁄ 4702] [1256 ⁄ 24 579] 0.963 (0.887–1.045) 0.36
Stroke Boyd Orr 5 (3.8) 10 (5.4) 3 (4.4) 18 (4.7) 1.118 (0.571–2.188) 0.74 0.86
CaPS 42 (10.3) 79 (11.5) 28 (10.5) 149 (11.0) 1.023 (0.801–1.306) 0.86
ELSA 69 (4.1) 92 (3.4) 35 (3.3) 196 (3.6) 0.876 (0.713–1.076) 0.21
HAS 6 (3.9) 6 (2.3) 3 (3.0) 15 (2.9) 0.814 (0.383–1.729) 0.59
HCS 44 (4.9) 42 (3.0) 26 (5.2) 112 (4.0) 0.963 (0.733–1.266) 0.79
Pooled [166 ⁄ 3261] [229 ⁄ 5235] [95 ⁄ 1996] [490 ⁄ 10 492] 0.943 (0.827–1.076) 0.38
CaPS: Phase V; Boyd Orr: angina Phase II.
Het, heterogeneity; MI, myocardial infarction; CaPS, Caerphilly Prospective Study; ELSA, English Longitudinal Study of Ageing; HAS, Hertfordshire Ageing
Study; HCS, Hertfordshire Cohort Study; NCDS, National Child Development Study; NSHD, National Survey of Health and Development.
*No. of participants with event (%); Pooled: [no. participants with event ⁄ total no. of participants with relevant data].
†Odds ratio per T allele.
Table 4 Anthropometry and biological function by genotype (pooled results)
Variable Total b (95% CI)* P-value Het P-value
BMI (kg m)2) 25 336 0.009 ()0.009 to 0.026) 0.33 0.81
Waist–hip ratio 22 134 )0.001 ()0.020 to 0.018) 0.93 0.72
Systolic blood pressure (mmHg) 25 030 )0.003 ()0.020 to 0.015) 0.77 0.67
Diastolic blood pressure (mmHg) 25 027 0.009 ()0.008 to 0.027) 0.29 0.75
Pulse rate (BPM) 18 355 0.007 ()0.018 to 0.033) 0.58 0.26
Forced vital capacity (L) 19 333 )0.001 ()0.027 to 0.025) 0.93 0.24
Forced expiratory volume (L) 19 338 )0.002 ()0.022 to 0.018) 0.86 0.47
Fibrinogen (g L)) 20 028 0.024 ()0.001 to 0.049) 0.06 0.23
Total cholesterol (mM) 23 098 0.020 ()0.003 to 0.043) 0.09 0.24
HDL cholesterol (mM) 23 616 0.014 ()0.018 to 0.045) 0.39 0.0207
Log triglycerides (mM) 24 279 )0.001 ()0.020 to 0.018) 0.91 0.39
LDL cholesterol (mM) 22 985 0.013 ()0.006 to 0.031) 0.18 0.67
Glucose† 22 572 0.001 ()0.017 to 0.020) 0.88 0.50
Het, heterogeneity.
*Beta coefficients per T allele based on z-scores.
†On scale 10 · (glucose in mM or HbA1c in %))2.
TERT SNP and age-related phenotypes, T. Alfred et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
525
erally rises with age (Nordling, 1953; DePinho, 2000; Cancer
Research UK, 2010), it is an important finding that this well-
powered multicohort study found that it was not associated
with poorer outcomes for other aging phenotypes. Indeed, our
range of investigated traits was extensive, including measures of
cognitive and physical capability, blood pressure, lung function
and blood lipid levels. Additionally, subgroup analysis demon-
strated that on the whole, the effects were similar for men and
women and for those aged below and at least 70 years.
However, it remains possible that either telomere length or
telomere maintenance functions could still influence age-
related traits despite the apparent absence of association
between rs401681 and age-related traits in our study. First, the
SNP may not substantially influence telomere length in this age
group as there are conflicting reports on the relationship with
rs401681 and telomere length, with the C allele associating
with shorter telomeres in an elderly set of females (Rafnar et al.,
2009), whereas no association was observed among adults
across a wider age span in recent reports (Mirabello et al.,
2010; Pooley et al., 2010; Prescott et al., 2010). Additionally,
no association with telomere length was found around the
TERT gene in a genome-wide association study (Levy et al.,
2010), nor in two candidate gene studies that also considered
other SNPs in the region (Mirabello et al., 2010; Prescott et al.,
2010). This would indicate that the lack of association observed
in this study is not because of the choice of common polymor-
phism within the TERT-CLPTM1L locus, although mutations in
the region may influence telomere length (Diaz de Leon et al.,
2010). Furthermore, telomere ‘length’ commonly assessed by
the Cawthon assay, which measures total telomere repeats
(Baird, 2005), is a crude phenotype which may not represent
aspects of individual telomeres differentially relevant in cancer
vs. aging traits. Second, either telomere length or another fea-
ture of telomere function could be important to age-related
traits through a mechanism distinct from that by which
rs401681 influences cancer risk (Baird, 2010). Other SNPs influ-
encing telomere length or function might be useful to further
explore these possibilities, particularly given the overall telomere
length variability explained by identified genetic loci so far have
been low (Codd et al., 2010).
Conclusion
Despite being associated with several cancers, the results of this
large, multicohort investigation into a comprehensive range of
aging phenotypes in a middle- to older-aged UK population do
not support the hypothesis that SNP rs401681 in the TERT-
CLPTM1L locus influences other aging traits.
Methods
Study populations
The Boyd Orr cohort is a historical cohort study based on chil-
dren surveyed in 1937–1939 in English and Scottish districts.
Participants were followed up in 1997–1998 (Phase II) and again
in 2002–2003 (Phase III), during which DNA was extracted from
728 adults. Details of the study design and the data collected
have been described elsewhere (Martin et al., 2005).
The Caerphilly Prospective Study (CaPS) recruited 2512 men
aged between 45 and 59 years in 1979–1983 from the town of
Caerphilly, South Wales, and its surrounding villages. Blood
samples were collected at baseline and at each of the four fol-
low-ups (Phase II: 1984–1988, Phase III: 1989–1993, Phase IV:
1993–1997 and Phase V: 2002–2004.) Further details are avail-
able on the cohort’s website (http://www.epi.bris.ac.uk/caer-
philly/caerphillyprospectivestudy.htm).
The English Longitudinal Study of Ageing contains men and
women aged 50 years and over who originally participated in
the Health Survey for England in 1998, 1999 or 2001. ELSA
fieldwork began in 2002–2003 (Phase I) with two-yearly follow-
ups in 2004–2005 (Phase II), during which blood samples were
provided by 6231 participants, 2006–2007 (Phase III) and 2008–
2009 (Phase IV). Details of the cohort are available elsewhere
(Marmot et al., 2003).
The Hertfordshire Ageing Study comprises men and women
traced in 1994–1995, the first follow-up (Phase I), from single-
ton live births in 1920–1930 in North Hertfordshire. A total of
717 participants attended a clinic during which DNA was
extracted. A second follow-up took place in 2003–2005 (Phase
II). Details of the recruitment, data collected and summaries of
participant characteristics have been described elsewhere (Syd-
dall et al., 2009).
The Hertfordshire Cohort Study is a younger and larger
cohort, with 2997 participants born in 1931–1939 and regis-
tered with a General Practitioner in East, North and West Hert-
fordshire attending a clinic in 1994–2004 (Phase I). A second
assessment took place in 2004–2005 for participants in East
Hertfordshire (Phase II). Further details of study design, data col-
lected and summaries of participant characteristics are available
(Syddall, 2005).
The Lothian Birth Cohort 1921 Study (LBC1921) participants
were all born in 1921 and completed an IQ assessment age 11.
In 1999–2001 (Phase I), 550 79-year-olds, living in and around
Edinburgh, attended a clinic, and in 2003–2005 (Phase II) 321
returned at 83 years old. Details of the recruitment into the
study are available on its website (http://www.lothianbirthcohort.
ed.ac.uk) and elsewhere (Deary et al., 2004; Gow et al., 2008).
The National Child Development Study (NCDS) follows individ-
uals from all births in England, Scotland and Wales during
1 week in March 1958. In 2002–2004, a Biomedical Survey was
conducted during home visits by a research nurse. DNA was
extracted from 8017 participants aged 44–45 years; the sample
with immortalized cell line culture (n = 7526) is used here. In
2008–2009, an eighth sweep was carried out during which cog-
nitive performance tests were conducted. Further details of the
study are available (Power & Elliott, 2006).
The Medical Research Council National Survey of Health and
Development (NSHD) comprises participants sampled from all
births in a week in March 1946 and followed up since. In 1999,
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at age 53 years, men and women were visited by a research
nurse and consent for DNA extraction was given by approxi-
mately 2900 members of the cohort. Details of the data
collected and the several phases of the study are available on
the cohort’s website http://www.nshd.mrc.ac.uk and elsewhere
(Wadsworth et al., 2006).
The Whitehall II study targeted all civil servants aged between
35 and 55 years working in London in 1985–1988. In 2002–
2004 (Phase VII), the genetics study was established and DNA
was extracted from 6156 participants. Details of the study
design and data collected have been described (Marmot & Brun-
ner, 2005).
Genotyping and quality control
Genotyping for SNP rs401681 for all cohorts, except LBC1921,
was carried out by KBioscience (http://www.kbio-
science.co.uk). Genotype information from LBC1921 came
from a genome-wide scan performed on the Illumina
Human610-Quadv1 Chip (http://www.illumina.com) (Houlihan
et al., 2010). Genotypic data quality was reviewed by assessing
departure from Hardy–Weinberg equilibrium (HWE), clustering
quality (using KBioscience software SNPviewer on their data)
and call rates.
Phenotypes
Cognitive capability
A number of cognitive performance tests in the different studies
were used to assess cognitive capability, the capacity to under-
take the mental tasks of daily living. The National Adult Reading
Test (Nelson & Willison, 1991) (NART) is a widely used assess-
ment of crystallized intelligence, i.e. acquired vocabulary and
knowledge, which was measured in CaPS, LBC1921 and NSHD.
The Alice Heim 4-I (Heim, 1970) (AH4) test was used in CaPS,
HAS and Whitehall II, and assesses fluid intelligence, i.e. reason-
ing ability, particularly in novel situations. The Mill Hill vocabu-
lary test (Raven, 1965) was used to measure crystallized verbal
intelligence in HAS and Whitehall II. Different assessments of
verbal memory were conducted: in ELSA and NCDS, a list of 10
common words were used, with participants asked to recall the
list immediately and again after a delay, the mean score was
used in the analysis; in NSHD, 15 words were used over three tri-
als; in Whitehall II 20 words were used; responses in NSHD and
Whitehall II were given in writing. Logical Memory from the
Wechsler Memory Scale-Revised (Wechsler, 1987) was used in
LBC1921. In Whitehall II, participants recalled in writing in 1 min
as many words as possible beginning with ‘S’ to assess
phonemic fluency, while in LBC1921 three letters ‘C’, ‘F’ and ‘L’
were used with responses given orally. Participants were
asked to recall as many animals as possible within 1 min to
measure semantic fluency; responses were given orally in CaPS,
ELSA, NCDS and NSHD, and in writing in Whitehall II. To assess
search speed (Richards et al., 1999), 1-min letter searches
among grids of letters were used, 600 letters in NSHD and 780
in ELSA and NCDS. Nonverbal reasoning was measured using
Raven’s Standard Progressive Matrices in LBC1921 (Raven et al.,
1977).
Physical capability
A number of physical performance tests were used to assess
physical capability, the capacity to undertake the physical tasks
of daily living. Grip strength was measured in ELSA, HAS, HCS,
LBC1921 and NSHD using electronic or hydraulic dynamome-
ters, with the best measure used in the analysis where more
than one trial was conducted. Several standing balance tests
were conducted in the cohorts, with participants’ eyes open:
Flamingo (Committee of Experts on Sports Research, 1993)
(stopped at 30 s) in Boyd Orr, CaPS, HAS and HCS; side-by-side,
semi-tandem and full tandem (Stevens et al., 2008) in ELSA; a
30-s one-legged stance in NSHD. The timed get up and go test
(Podsiadlo & Richardson, 1991) was carried out in Boyd Orr,
CaPS, HAS and HCS and required participants to get up from a
chair, walk 3 m, turn, walk back, turn and sit down. Timed
walks over 2.44 m (8 feet) and 6 m were carried out in ELSA
and LBC1921, respectively, with the fastest time used in the
analysis where more than one trial was conducted. Timed chair
rises (Csuka & McCarty, 1985) involved asking participants to
rise from a chair and sit back down five times in ELSA, HAS and
HCS, and 10 times in NSHD.
Anthropometry and biological function
Several measures of anthropometry and biological function
were used, where available in the cohorts. BMI (kg m)2) was cal-
culated as weight divided by height squared derived from mea-
surements conducted at clinics or during a clinical interview in
the home where available, or from self-reports. WHR was
defined as waist circumference (cm) divided by hip circumfer-
ence (cm). Where more than one sitting systolic, diastolic blood
pressure (mmHg) or pulse rate (BPM) measurement was
recorded at the clinical interview, the mean values were used in
analysis. Spirometry was used to assess lung function: Forced
vital capacity (L) and forced expiratory volume in 1 s (L); the
highest value was used in the analyses. Blood samples were used
to measure fibrinogen (g L)1), total, low-density lipoprotein
(LDL) and high-density lipoprotein (HDL) cholesterol (mM), trigly-
cerides (mM), fasting glucose (mM) and nonfasting glycosylated
haemoglobin (HbA1c, %).
Health history
History of myocardial infarction (MI), angina, any diabetes and
stroke were derived from self-reports and, where possible, from
GP and hospital records.
Demographic variables
Data collected on age, sex, smoking status and physical activity
were used to assess whether MAF varied by these variables
within the cohorts. Where information on ethnicity was col-
lected, non-white participants were excluded from analyses to
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avoid confounding from population stratification (Cordell &
Clayton, 2005).
Statistical methods
Statistical analysis was performed in STATA 11.1 (StataCorp LP,
College Station, Texas, USA ). Linear and logistic regression anal-
yses were conducted on the continuous and dichotomous traits
within the cohorts respectively. Additive models were used with
genotypes coded as 0, 1 and 2 for the number of minor (T)
alleles. Likelihood ratio tests were used to compare the fit of the
additive models compared to the full genotype model. For con-
tinuous traits, the normality of the standardized residuals was
inspected with distributional diagnostic plots. To improve the
normality, natural log transformations were carried out on timed
get up and go, timed walks and triglycerides. A power transfor-
mation of )2 was used on glucose and HbA1c. As with previous
analyses (Kuh et al., 2005), the reciprocal of time taken in sec-
onds · 100 was used for chair rises. Cook’s distances (Cook,
2000) were plotted against fitted values, using a cut-off of four
divided by sample size, to identify influential outliers in the con-
tinuous phenotypes. For the harmonization of continuous traits
that were used to obtain pooled estimates of the genotypic
effects, z-score units were calculated in each cohort by subtract-
ing the cohort mean and dividing by its standard deviation. The
overall mean for z-scores is 0 and standard deviation 1. Beta
coefficients calculated on z-score units can be reverted to the
original scale by multiplying by an appropriate standard devia-
tion. Two-step (Riley et al., 2010) meta-analyses were per-
formed to obtain pooled genotypic effects, with the random-
effects’ estimates presented in the tables. Meta-analyses were
also stratified by sex, cigarette smoking status and physical activ-
ity (any vs. none, or any vigorous vs. none in ELSA and Whitehall
II), chosen a priori. Meta-analyses were repeated after the
removal of the identified influential data in the continuous traits,
and results are reported on the complete data; unless the overall
effect, the overall heterogeneity or the heterogeneity between
subgroups were no longer significant, where the reporting is
then from the restricted datasets. Within-study investigations
were made in ELSA, the study with the widest age range, to
assess whether the effects of genotype differed in individuals
aged below and at least 70 years. In addition, within-study
investigations were made into follow-up measures of cognitive
and physical capability adjusting for the measure in an earlier
phase. Reporting met the appropriate items of a recommended
checklist (Stroup et al., 2000). Quanto (Gauderman & Morrison,
2006) was used for power calculations using a MAF of 0.44. A
two-tailed significance level of P < 0.05 was used.
Acknowledgments and funding
We thank Alan J Gow and Alison Pattie for their very useful com-
ments on the paper. We thank Kate Birnie, Vanessa Cox, Nikki
Graham, Karen Jameson, Jon Johnson, Aida Sanchez, Andrew
Taylor and Andrew Wong for providing the data. We acknowl-
edge the support of Medical Research Council and Arthritis
Research (UK). Boyd Orr funding: The Boyd Orr DNA bank was
funded by the Wellcome Trust (Grant number: GR068468MA).
Follow-up of the Boyd Orr cohort was supported by grants from
the Wellcome Trust, World Cancer Research Fund and the Brit-
ish Heart Foundation. The CaPS was conducted by the former
MRC Epidemiology Unit (South Wales) and funded by the Medi-
cal Research Council of the United Kingdom. The Department of
Social and Community Medicine, University of Bristol now main-
tains the archive. We thank the Lothian Birth Cohort 1921 par-
ticipants. We thank the Scottish Council for Research in
Education for allowing access to the Scottish Mental Survey
1932. The Biotechnology and Biological Sciences Research
Council (BBSRC) funded the phenotypic data collection and
DNA preparation (project grant 15 ⁄ SAG09977) and GWAS (pro-
ject grant BB ⁄ F019394 ⁄ 1). The work was undertaken by The
University of Edinburgh Centre for Cognitive Ageing and Cogni-
tive Epidemiology, part of the cross council Lifelong Health and
Wellbeing Initiative (Centre grant G0700704 ⁄ 84698). Funding
from the BBSRC, Engineering and Physical Sciences Research
Council (EPSRC), Economic and Social Research Council (ESRC)
and Medical Research Council (MRC) is gratefully acknowl-
edged. NCDS 1958 British birth cohort: Phenotype measures
(blood pressure, etc.) and DNA collection were funded by the
MRC (project grant G0000934), and creation of immortalized
cell lines by Wellcome Trust Grant 068545 ⁄ Z ⁄ 02. The MRC Cen-
tre of Epidemiology for Child Health is funded by the MRC.
Great Ormond Street Hospital ⁄University College London, Insti-
tute of Child Health receives a proportion of funding from the
Department of Health’s National Institute of Health Research
(‘Biomedical Research Centres’ funding). The MRC NSHD is
funded by the UK Medical Research Council. Whitehall II fund-
ing: the Medical Research Council; British Heart Foundation;
Health and Safety Executive; Department of Health; National
Heart Lung and Blood Institute (NHLBI, R01HL36310), US, NIH:
National Institute on Aging (NIA, R01AG013196 and
R01AG034454), US, NIH; Agency for Health Care Policy
Research (HS06516); and the John D and Catherine T MacAr-
thur Foundation Research Networks on Successful Midlife Devel-
opment and Socio-economic Status and Health. Me.K. and Mi.
K. are supported by NHLBI, and Mi.K. is additionally supported
by the Academy of Finland, the BUPA Foundation, UK, and NIA,
US. DG is an NIHR Senior Investigator. RC receives support from
the HALCyon programme funded by the New Dynamics of Age-
ing (RES-353-25-0001). DK and RH are supported by the UK
Medical Research Council. TA is an ESRC PhD student.
Competing interests
The authors declare no competing interests.
References
Andrew T, Aviv A, Falchi M, Surdulescu GL, Gardner JP, Lu X,
Kimura M, Kato BS, Valdes AM, Spector TD (2006) Mapping
TERT SNP and age-related phenotypes, T. Alfred et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
528
genetic loci that determine leukocyte telomere length in a large
sample of unselected female sibling pairs. Am. J. Hum. Genet. 78,
480–486.
Andrew A, Gui J, Sanderson A, Mason R, Morlock E, Schned A, Kelsey
K, Marsit C, Moore J, Karagas M (2009) Bladder cancer SNP panel
predicts susceptibility and survival. Hum. Genet. 125, 527–539.
Atzmon G, Cho M, Cawthon RM, Budagov T, Katz M, Yang X, Siegel
G, Bergman A, Huffman DM, Schechter CB, Wright WE, Shay JW,
Barzilai N, Govindaraju DR, Suh Y (2010) Evolution in health and
medicine Sackler colloquium: genetic variation in human telomerase
is associated with telomere length in Ashkenazi centenarians. Proc.
Natl Acad. Sci. USA 107(Suppl. 1), 1710–1717.
Aviv A (2006) Telomeres and human somatic fitness. J. Gerontol.
A Biol. Sci. Med. Sci. 61, 871–873.
Baird DM (2005) New developments in telomere length analysis. Exp.
Gerontol. 40, 363–368.
Baird DM (2010) Variation at the TERT locus and predisposition for
cancer. Expert Rev. Mol. Med. 12, e16.
Bakaysa SL, Mucci LA, Slagboom PE, Boomsma DI, McClearn GE,
Johansson B, Pedersen NL (2007) Telomere length predicts survival
independent of genetic influences. Aging Cell 6, 769–774.
Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, Skurnick J,
Labat C, Bean K, Aviv A (2001) Telomere length as an indicator of
biological aging: the gender effect and relation with pulse pressure
and pulse wave velocity. Hypertension 37, 381–385.
Bischoff C, Graakjaer J, Petersen HC, Hjelmborg JVB, Vaupel JW, Bohr
V, Koelvraa S, Christensen K (2005) The heritability of telomere
length among the elderly and oldest-old. Twin Res. Hum. Genet. 8,
433–439.
Blasco MA (2005) Telomeres and human disease: ageing, cancer and
beyond. Nat. Rev. Genet. 6, 611–622.
Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, Eisen
T, Amos CI, Houlston RS (2009) Deciphering the impact of common
genetic variation on lung cancer risk: a genome-wide association
study. Cancer Res. 69, 6633–6641.
Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shep-
herd J, Packard CJ, Samani NJ (2007) Telomere length, risk of coro-
nary heart disease, and statin treatment in the West of Scotland
Primary Prevention Study: a nested case-control study. Lancet 369,
107–114.
Calado RT, Young NS (2009) Telomere diseases. N. Engl. J. Med. 361,
2353–2365.
Cancer Research UK (2010) Cancer incidence by age – UK statistics.
Available at: http://info.cancerresearchuk.org/cancerstats/incidence/
age/ [accessed on 2 August 2010].
Canela A, Vera E, Klatt P, Blasco MA (2007) High-throughput telo-
mere length quantification by FISH and its application to human
population studies. Proc. Natl. Acad. Sci. U S A 104, 5300–5305.
Catarino R, Arau´jo A, Coelho A, Gomes M, Nogueira A, Lopes C,
Medeiros RM (2010) Prognostic significance of telomerase polymor-
phism in non-small cell lung cancer. Clin. Cancer Res. 16, 3706–
3712.
Chan SRWL, Blackburn EH (2004) Telomeres and telomerase. Philos.
Trans. R. Soc. Lond., B, Biol. Sci 359, 109–121.
Choi J, Kang H, Jang J, Choi Y, Kim M, Kim J, Jeon H, Lee W, Cha S,
Kim C, Kam S, Jung T, Park J (2009) Polymorphisms in telomere
maintenance genes and risk of lung cancer. Cancer Epidemiol. Bio-
markers Prev. 18, 2773–2781.
Codd V, Mangino M, van der Harst P, Braund PS, Kaiser M, Beveridge
AJ, Rafelt S, Moore J, Nelson C, Soranzo N, Zhai G, Valdes AM,
Blackburn H, Leach IM, de Boer RA, Goodall AH, Ouwehand W, van
Veldhuisen DJ, van Gilst WH, Navis G, Burton PR, Tobin MD, Hall
AS, Thompson JR, Spector T, Samani NJ (2010) Common variants
near TERC are associated with mean telomere length. Nat. Genet.
42, 197–199.
Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR
(2007) Protein composition of catalytically active human telomerase
from immortal cells. Science 315, 1850–1853.
Committee of Experts on Sports Research (1993) Eurofit: Handbook
for the EUROFIT Tests of Physical Fitness, 2nd edn. Strasbourg:
Council of Europe.
Cook RD (2000) Detection of influential observation in linear regres-
sion. Technometrics 42, 65–68.
Cordell HJ, Clayton DG (2005) Genetic association studies. Lancet
366, 1121–1131.
Csuka M, McCarty DJ (1985) Simple method for measurement of
lower extremity muscle strength. Am. J. Med. 78, 77–81.
Deary IJ, Whiteman MC, Starr JM, Whalley LJ, Fox HC (2004) The
impact of childhood intelligence on later life: following up the Scot-
tish mental surveys of 1932 and 1947. J. Pers. Soc. Psychol. 86,
130–147.
DePinho RA (2000) The age of cancer. Nature 408, 248–254.
Diaz de Leon A, Cronkhite JT, Katzenstein AA, Godwin JD, Raghu G,
Glazer CS, Rosenblatt RL, Girod CE, Garrity ER, Xing C, Garcia CK
(2010) Telomere lengths, pulmonary fibrosis and telomerase (TERT)
mutations. PLoS ONE 5, e10680.
Gauderman W, Morrison J (2006) QUANTO 1.1: a computer program
for power and sample size calculations for genetic-epidemiology
studies. Available at: http://hydra.usc.edu/gxe/ [accessed on 18
November 2010].
Gow AJ, Johnson W, Pattie A, Whiteman MC, Starr J, Deary IJ (2008)
Mental ability in childhood and cognitive aging. Gerontology 54,
177–186.
Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson
I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ,
Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A,
Holm H, Bjornsdottir US, Eyjolfsson GI, Navarrete S, Fuertes F, Gar-
cia-Prats MD, Polo E, Checherita IA, Jinga M, Badea P, Aben KK,
Schalken JA, van Oort IM, Sweep FC, Helfand BT, Davis M, Donovan
JL, Hamdy FC, Kristjansson K, Gulcher JR, Masson G, Kong A, Cata-
lona WJ, Mayordomo JI, Geirsson G, Einarsson GV, Barkardottir RB,
Jonsson E, Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir
U, Rafnar T, Stefansson K (2010) Genetic correction of PSA values
using sequence variants associated with PSA levels. Sci. Transl. Med.
2, 62ra92.
Heim A (1970) AH4 Group Test of Intelligence. Windsor: NFER-Nelson.
Hosgood HD, Cawthon R, He X, Chanock S, Lan Q (2009) Genetic
variation in telomere maintenance genes, telomere length, and lung
cancer susceptibility. Lung Cancer 66, 157–161.
Houlihan LM, Davies G, Tenesa A, Harris SE, Luciano M, Gow AJ,
McGhee KA, Liewald DC, Porteous DJ, Starr JM (2010) Common
variants of large effect in F12, KNG1, and HRG are associated with
activated partial thromboplastin time. Am. J. Hum. Genet. 86, 626–
631.
Hsiung CA, Lan Q, Hong Y, Chen C, Hosgood HD, Chang I, Chatter-
jee N, Brennan P, Wu C, Zheng W, Chang G, Wu T, Park JY, Hsiao
C, Kim YH, Shen H, Seow A, Yeager M, Tsai Y, Kim YT, Chow WH,
Guo H, Wang WC, Sung SW, Hu Z, Chen KY, Kim JH, Chen Y,
Huang L, Lee KM, Lo YL, Gao YT, Kim JH, Liu L, Huang MS, Jung
TH, Jin G, Caporaso N, Yu D, Kim CH, Su WC, Shu XO, Xu P, Kim
IS, Chen YM, Ma H, Shen M, Cha SI, Tan W, Chang CH, Sung JS,
Zhang M, Yang TY, Park KH, Yuenger J, Wang CL, Ryu JS, Xiang Y,
Deng Q, Hutchinson A, Kim JS, Cai Q, Landi MT, Yu CJ, Park JY,
Tucker M, Hung JY, Lin CC, Perng RP, Boffetta P, Chen CY, Chen
TERT SNP and age-related phenotypes, T. Alfred et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
529
KC, Yang SY, Hu CY, Chang CK, Fraumeni JF Jr, Chanock S, Yang
PC, Rothman N, Lin D (2010) The 5p15.33 locus is associated with
risk of lung adenocarcinoma in never-smoking females in Asia. PLoS
Genet. 6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/
20700438 [accessed on 2 February 2011].
Huda N, Tanaka H, Herbert B, Reed T, Gilley D (2007) Shared environ-
mental factors associated with telomere length maintenance in
elderly male twins. Aging Cell 6, 709–713.
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB,
deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman
MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB,
Chang-Claude J, Wang-Gohrke S, Cramer DW, Terry KL, Hankinson
SE, Tworoger SS, Garcia-Closas M, Yang H, Lissowska J, Chanock
SJ, Pharoah PD, Song H, Whitemore AS, Pearce CL, Stram DO, Wu
AH, Pike MC, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A,
Anton-Culver H, Ziogas A, Hogdall E, Kjaer SK, Hogdall C, Berchuck
A, Schildkraut JM, Iversen ES, Moorman PG, Phelan CM, Sellers TA,
Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chene-
vix-Trench G; Ovarian Cancer Association Consortium; Australian
Ovarian Cancer Study Group; Australian Cancer Study (Ovarian
Cancer) (2010) Evaluation of candidate stromal epithelial cross-talk
genes identifies association between risk of serous ovarian cancer
and TERT, a cancer susceptibility ‘‘hot-spot’’. PLoS Genet. 6,
e1001016.
Kamatani Y, Matsuda K, Okada Y, Kubo M, Hosono N, Daigo Y,
Nakamura Y, Kamatani N (2010) Genome-wide association study of
hematological and biochemical traits in a Japanese population. Nat.
Genet. 42, 210–215.
Kirkwood TBL (2008) A systematic look at an old problem. Nature
451, 644–647.
Kohno T, Kunitoh H, Shimada Y, Shiraishi K, Ishii Y, Goto K, Ohe Y,
Nishiwaki Y, Kuchiba A, Yamamoto S, Hirose H, Oka A, Yanagitani
N, Saito R, Inoko H, Yokota J (2010) Individuals susceptible to lung
adenocarcinoma defined by combined HLA-DQA1 and TERT geno-
types. Carcinogenesis 31, 834–841.
Kuh D, Bassey EJ, Butterworth S, Hardy R, Wadsworth MEJ (2005)
Grip strength, postural control, and functional leg power in a repre-
sentative cohort of British men and women: associations with physi-
cal activity, health status, and socioeconomic conditions.
J. Gerontol. A Biol. Sci. Med. Sci. 60, 224–231.
Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M,
Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Con-
sonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo
J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C,
Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin
J, Wang Y, Tsao MS, Spitz MR, Wang Y, Krokan H, Vatten L, Skorpen
F, Arnesen E, Benhamou S, Bouchard C, Metsapalu A, Vooder T, Nelis
M, Va¨lk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G,
Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickebo¨ller H, Risch A,
Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI,
Fraumeni JF Jr, Savage SA, Bertazzi PA, Tucker MA, Chanock S,
Caporaso NE (2009) A genome-wide association study of lung cancer
identifies a region of chromosome 5p15 associated with risk for ade-
nocarcinoma. Am. J. Hum. Genet. 85, 679–691.
Levy D, Neuhausen SL, Hunt SC, Kimura M, Hwang S, Chen W, Bis
JC, Fitzpatrick AL, Smith E, Johnson AD, Gardner JP, Srinivasan SR,
Schork N, Rotter JI, Herbig U, Psaty BM, Sastrasinh M, Murray SS,
Vasan RS, Province MA, Glazer NL, Lu X, Cao X, Kronmal R, Man-
gino M, Soranzo N, Spector TD, Berenson GS, Aviv A (2010)
Genome-wide association identifies OBFC1 as a locus involved in
human leukocyte telomere biology. Proc. Natl. Acad. Sci. U S A
107, 9293–9298.
Ludlow AT, Zimmerman JB,Witkowski S, Hearn JW, Hatfield BD, Roth SM
(2008) Relationship between physical activity level, telomere length,
and telomerase activity.Med. Sci. Sports Exerc. 40, 1764–1771.
Mangino M, Brouilette S, Braund P, Tirmizi N, Vasa-Nicotera M,
Thompson JR, Samani NJ (2008) A regulatory SNP of the BICD1
gene contributes to telomere length variation in humans. Hum.
Mol. Genet. 17, 2518–2523.
Mangino M, Richards JB, Soranzo N, Zhai G, Aviv A, Valdes AM,
Samani NJ, Deloukas P, Spector TD (2009) A genome-wide associa-
tion study identifies a novel locus on chromosome 18q12.2 influenc-
ing white cell telomere length. J. Med. Genet. 46, 451–454.
Marmot M, Brunner E (2005) Cohort profile: the Whitehall II study.
Int. J. Epidemiol. 34, 251–256.
Marmot M, Banks J, Blundell R, Lessof C, Nazroo J (2003) Health,
wealth and lifestyles of the older population in England: The 2002
English Longitudinal Study of Ageing. London: Institute for Fiscal
Studies.
Martin RM, Gunnell D, Pemberton J, Frankel S, Davey Smith G (2005)
Cohort profile: the Boyd Orr cohort – an historical cohort study
based on the 65 year follow-up of the Carnegie Survey of Diet and
Health (1937-39). Int. J. Epidemiol. 34, 742–749.
Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, Zglinicki TV
(2006) Telomere length predicts poststroke mortality, dementia, and
cognitive decline. Ann. Neurol. 60, 174–180.
Matsubara Y, Murata M, Watanabe K, Saito I, Miyaki K, Omae K,
Ishikawa M, Matsushita K, Iwanaga S, Ogawa S (2006a) Coronary
artery disease and a functional polymorphism of hTERT. Biochem.
Biophys. Res. Commun. 348, 669–672.
Matsubara Y, Murata M, Yoshida T, Watanabe K, Saito I, Miyaki K,
Omae K, Ikeda Y (2006b) Telomere length of normal leukocytes is
affected by a functional polymorphism of hTERT. Biochem. Biophys.
Res. Commun. 341, 128–131.
Matteini AM, Fallin MD, Kammerer CM, Schupf N, Yashin AI, Chris-
tensen K, Arbeev KG, Barr G, Mayeux R, Newman AB, Walston JD
(2010) Heritability estimates of endophenotypes of long and health
life: the Long Life Family Study. J. Gerontol. A Biol. Sci. Med. Sci.
65, 1375–1379.
McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA,
Plomin R (1997) Substantial genetic influence on cognitive abilities
in twins 80 or more years old. Science 276, 1560–1563.
McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G,
Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai
P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, McLaugh-
lin J, Shepherd F, Montpetit A, Narod S, Krokan HE, Skorpen F,
Elvestad MB, Vatten L, Njølstad I, Axelsson T, Chen C, Goodman G,
Barnett M, Loomis MM, Lubin˜ski J, Matyjasik J, Lener M, Oszu-
towska D, Field J, Liloglou T, Xinarianos G, Cassidy A; EPIC Study,
Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S,
Gonza´lez CA, Ramo´n Quiro´s J, Martı´nez C, Navarro C, Ardanaz E,
Larran˜aga N, Kham KT, Key T, Bueno-de-Mesquita HB, Peeters PH,
Trichopoulou A, Linseisen J, Boeing H, Hallmans G, Overvad K, Tjøn-
neland A, Kumle M, Riboli E, Zelenika D, Boland A, Delepine M,
Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop
M, Brennan P (2008) Lung cancer susceptibility locus at 5p15.33.
Nat. Genet. 40, 1404–1406.
Miki D, Kubo M, Takahashi A, Yoon K, Kim J, Lee GK, Zo JI, Lee JS,
Hosono N, Morizono T, Tsunoda T, Kamatani N, Chayama K, Takah-
ashi T, Inazawa J, Nakamura Y, Daigo Y (2010) Variation in TP63 is
associated with lung adenocarcinoma susceptibility in Japanese and
Korean populations. Nat. Genet. 42, 893–896.
Mirabello L, Yu K, Kraft P, De Vivo I, Hunter DJ, Prescott J, Wong JYY,
Chatterjee N, Hayes RB, Savage SA (2010) The association of telo-
TERT SNP and age-related phenotypes, T. Alfred et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
530
mere length and genetic variation in telomere biology genes. Hum.
Mutat. 31, 1050–1058.
Mushiroda T, Wattanapokayakit S, Takahashi A, Nukiwa T, Kudoh S,
Ogura T, Taniguchi H, Kubo M, Kamatani N, Nakamura Y, the Pirfe-
nidone Clinical Study Group (2008) A genome-wide association
study identifies an association of a common variant in TERT with
susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 45,
654–656.
Nelson H, Willison J (1991) National Adult Reading Test (NART) Test
Manual (Part II). Windsor, UK: NFER-Nelson.
Nordling CO (1953) A new theory on cancer-inducing mechanism. Br.
J. Cancer 7, 68–72.
Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua
M, Marlin R, Yglecias L, Carroll P (2008) Increased telomerase activ-
ity and comprehensive lifestyle changes: a pilot study. Lancet Oncol.
9, 1048–1057.
Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solo-
mon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S,
Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li
D, Mandelson MT, Olson SH, Risch HA, Zheng W, Albanes D, Bam-
let WR, Berg CD, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian
F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Gio-
vannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M,
Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg
C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB,
Michaud DS, Parikh H, Patel AV, Peeters PH, Rajkovic A, Riboli E,
Rodriguez L, Seminara D, Shu XO, Thomas G, Tjønneland A, Tobias
GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-
Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A,
Fraumeni JF, Hoover RN, Hartge P, Chanock SJ (2010) A genome-
wide association study identifies pancreatic cancer susceptibility loci
on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet. 42,
224–228.
Podsiadlo D, Richardson S (1991) The timed ‘‘Up & Go’’: a test of
basic functional mobility for frail elderly persons. J. Am. Geriatr.
Soc. 39, 142–148.
Pooley KA, Tyrer J, Shah M, Driver KE, Leyland J, Brown J, Audley T,
McGuffog L, Ponder BAJ, Pharoah PDP, Easton DF, Dunning AM
(2010) No Association between TERT-CLPTM1L Single Nucleotide
Polymorphism rs401681 and Mean Telomere Length or Cancer Risk.
Cancer Epidemiol. Biomarkers Prev. 19, 1862–1865.
Power C, Elliott J (2006) Cohort profile: 1958 British birth cohort
(National Child Development Study). Int. J. Epidemiol. 35, 34–41.
Prescott J, McGrath M, Lee I, Buring JE, De Vivo I (2010) Telomere
length and genetic analyses in population-based studies of endome-
trial cancer risk. Cancer 116, 4275–4282.
Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A,
Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KKH, Blondal T,
Thorgeirsson TE, Thorleifsson G, Kristjansson K, Thorisdottir K, Rag-
narsson R, Sigurgeirsson B, Skuladottir H, Gudbjartsson T, Isaksson
HJ, Einarsson GV, Benediktsdottir KR, Agnarsson BA, Olafsson K,
Salvarsdottir A, Bjarnason H, Asgeirsdottir M, Kristinsson KT, Mat-
thiasdottir S, Sveinsdottir SG, Polidoro S, Ho¨iom V, Botella-Estrada
R, Hemminki K, Rudnai P, Bishop DT, Campagna M, Kellen E, Zee-
gers MP, de Verdier P, Ferrer A, Isla D, Vidal MJ, Andres R, Saez B,
Juberias P, Banzo J, Navarrete S, Tres A, Kan D, Lindblom A, Gurzau
E, Koppova K, de Vegt F, Schalken JA, van der Heijden HF, Smit HJ,
Termeer RA, Oosterwijk E, van Hooij O, Nagore E, Porru S, Steineck
G, Hansson J, Buntinx F, Catalona WJ, Matullo G, Vineis P, Kiltie
AE, Mayordomo JI, Kumar R, Kiemeney LA, Frigge ML, Jonsson T,
Saemundsson H, Barkardottir RB, Jonsson E, Jonsson S, Olafsson JH,
Gulcher JR, Masson G, Gudbjartsson DF, Kong A, Thorsteinsdottir
U, Stefansson K (2009) Sequence variants at the TERT-CLPTM1L
locus associate with many cancer types. Nat. Genet. 41, 221–227.
Raven J (1965) Guide to Using the Mill Hill Vocabulary Scale with Pro-
gressive Matrices. London: HK Lewis.
Raven J, Court J, Rven J (1977) Manual for Raven’s Progressive Matri-
ces and Vocabulary Scales. London: Lewis.
RichardsM,KuhD,Hardy R,WadsworthM (1999) Lifetime cognitive func-
tion and timing of the naturalmenopause.Neurology 53, 308–314.
Riley RD, Lambert PC, Abo-Zaid G (2010) Meta-analysis of individual
participant data: rationale, conduct, and reporting. BMJ 340, c221.
Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa
JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney
LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt
MAT, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayor-
domo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP,
Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardo´n A,
Serra C, Carrato A, Garcı´a-Closas R, Lloreta J, Johnson A, Schwenn
M, Karagas MR, Schned A, Andriole G Jr, Grubb R III, Black A,
Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis
VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ,
McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen
SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Ste-
fansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE,
Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT,
Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop
DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacer-
dote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich
H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey
A, Xu Z, Sanz-Velez JI, D Garcı´a-Prats M, Sanchez M, Valdivia G,
Porru S, Benhamou S, Hoover RN, Fraumeni JF Jr, Silverman DT,
Chanock SJ (2010) A multi-stage genome-wide association study of
bladder cancer identifies multiple susceptibility loci. Nat. Genet. 42,
978–984.
Ruiz-Llorente S, Montero-Conde C, Milne RL, Moya CM, Cebrian A,
Leton R, Cascon A, Mercadillo F, Landa I, Borrego S, de Nanclares
GP, Alvarez-Escola C, Diaz-Perez JA, Carracedo A, Urioste M, Gonz-
alez-Neira A, Benitez J, Santisteban P, Dopazo J, Ponder BA,
Robledo M; Medullary Thyroid Carcinoma Clinical Group (2007)
Association study of 69 genes in the ret pathway identifies low-pen-
etrance loci in sporadic medullary thyroid carcinoma. Cancer Res.
67, 9561–9567.
Shen J, Gammon MD, Wu H, Terry MB, Wang Q, Bradshaw PT, Teitel-
baum SL, Neugut AI, Santella RM (2010) Multiple genetic variants in
telomere pathway genes and breast cancer risk. Cancer Epidemiol.
Biomarkers Prev. 19, 219–228.
Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B,
Simon M, Marie Y, Boisselier B, Delattre J, Hoang-Xuan K, El Hallani
S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT,
Feychting M, Lo¨nn S, Ahlbom A, Schramm J, Linnebank M, Hem-
minki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X,
Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M,
Bondy M, Houlston RS (2009) Genome-wide association study iden-
tifies five susceptibility loci for glioma. Nat. Genet. 41, 899–904.
Slagboom PE, Droog S, Boomsma DI (1994) Genetic determination of
telomere size in humans: a twin study of three age groups. Am. J.
Hum. Genet. 55, 876–882.
Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G,
Jakobsdottir M, Sigurdsson A, Gudbjartsson DF, Sigurgeirsson B,
Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Scherer D, Hemm-
inki K, Rudnai P, Gurzau E, Koppova K, Botella-Estrada R, Soriano
V, Juberias P, Saez B, Gilaberte Y, Fuentelsaz V, Corredera C, Grasa
M, Ho¨iom V, Lindblom A, Bonenkamp JJ, van Rossum MM, Aben
TERT SNP and age-related phenotypes, T. Alfred et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
531
KK, de Vries E, Santinami M, Di Mauro MG, Maurichi A, Wendt J,
Hochleitner P, Pehamberger H, Gudmundsson J, Magnusdottir DN,
Gretarsdottir S, Holm H, Steinthorsdottir V, Frigge ML, Blondal T,
Saemundsdottir J, Bjarnason H, Kristjansson K, Bjornsdottir G,
Okamoto I, Rivoltini L, Rodolfo M, Kiemeney LA, Hansson J, Nagore
E, Mayordomo JI, Kumar R, Karagas MR, Nelson HH, Gulcher JR,
Rafnar T, Thorsteinsdottir U, Olafsson JH, Kong A, Stefansson K
(2009) New common variants affecting susceptibility to basal cell
carcinoma. Nat. Genet. 41, 909–914.
Starr J, Shiels P, Harris S, Pattie A, Pearce M, Relton C, Deary I (2008)
Oxidative stress, telomere length and biomarkers of physical aging
in a cohort aged 79 years from the 1932 Scottish Mental Survey.
Mech. Ageing Dev. 129, 745–751.
Stevens KN, Lang IA, Guralnik JM, Melzer D (2008) Epidemiology of
balance and dizziness in a national population: findings from the
English Longitudinal Study of Ageing. Age Ageing 37, 300–305.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D,
Moher D, Becker BJ, Sipe TA, Thacker SB, for the Meta-analysis of
Observational Studies in Epidemiology Group (2000) Meta-analysis
of observational studies in epidemiology: a proposal for reporting.
JAMA 283, 2008–2012.
Syddall H (2005) Cohort profile: the Hertfordshire Cohort Study. Int.
J. Epidemiol. 34, 1234–1242.
Syddall HE, Simmonds SJ, Martin HJ, Watson C, Dennison EM, Cooper
C, Sayer AA, for the Hertfordshire Cohort Study Group (2009)
Cohort profile: the Hertfordshire Ageing Study (HAS). Int. J. Epidem-
iol. 39, 36–43.
Tiainen K, Sipila S, Alen M, Heikkinen E, Kaprio J, Koskenvuo M, Tol-
vanen A, Pajala S, Rantanen T (2004) Heritability of maximal isomet-
ric muscle strength in older female twins. J. Appl. Physiol. 96, 173–
180.
Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, Rick-
etts M, Linger R, Nsengimana J, Deloukas P, Huddart RA, Bishop
DT, Easton DF, Stratton MR, Rahman N (2010) Variants near
DMRT1, TERT and ATF7IP are associated with testicular germ cell
cancer. Nat. Genet. 42, 604–607.
Valdes A, Andrew T, Gardner J, Kimura M, Oelsner E, Cherkas L, Aviv
A, Spector T (2005) Obesity, cigarette smoking, and telomere length
in women. Lancet 366, 662–664.
Van Dyke AL, Cote ML, Wenzlaff AS, Abrams J, Land S, Iyer P,
Schwartz AG (2009) Chromosome 5p region SNPs are associated
with risk of NSCLC among women. J Cancer Epidemiol. 2009,
242151.
Vasa-Nicotera M, Brouilette S, Mangino M, Thompson JR, Braund P,
Clemitson J, Mason A, Bodycote CL, Raleigh SM, Louis E, Samani NJ
(2005) Mapping of a major locus that determines telomere length
in humans. Am. J. Hum. Genet. 76, 147–151.
Volk HE, McDermott KB, Roediger HL, Todd RD (2006) Genetic influ-
ences on free and cued recall in long-term memory tasks. Twin Res.
Hum. Genet. 9, 623–631.
Wadsworth M, Kuh D, Richards M, Hardy R (2006) Cohort profile: the
1946 National Birth Cohort (MRC National Survey of Health and
Development). Int. J. Epidemiol. 35, 49–54.
Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A,
Qureshi M, Dong Q, Gu X, Chen WV, Spitz MR, Eisen T, Amos CI,
Houlston RS (2008) Common 5p15.33 and 6p21.33 variants influ-
ence lung cancer risk. Nat. Genet. 40, 1407–1409.
Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS (2010) Role
of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-
CHRNA3) variation and lung cancer risk in never-smokers. Carcino-
genesis 31, 234–238.
Wechsler D (1987) Wechsler Memory Scale-Revised. New York: Psy-
chological Corp.
Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y (2001) A
novel gene, CRR9, which was up-regulated in CDDP-resistant ovar-
ian tumor cell line, was associated with apoptosis. Biochem. Bio-
phys. Res. Commun. 280, 1148–1154.
von Zglinicki T (2002) Oxidative stress shortens telomeres. Trends Bio-
chem. Sci. 27, 339–344.
Zienolddiny S, Skaug V, Landvik NE, Ryberg D, Phillips DH, Houlston R,
Haugen A (2009) The TERT-CLPTM1L lung cancer susceptibility vari-
ant associates with higher DNA adduct formation in the lung. Carci-
nogenesis 30, 1368–1371.
Supporting Information
Additional supporting information may be found in the online
version of this article:
Figs S1–S28 Forest plots from meta-analyses.
Table S1 Minor allele frequencies by sex and age group for all
cohorts combined.
Table S2 Anthropometry and biological function by genotype
and cohort (full results).
Table S3 Summary of the reported associations between SNP
rs401681 and cancers.
As a service to our authors and readers, this journal provides
supporting information supplied by the authors. Such materials
are peer-reviewed and may be re-organized for online delivery,
but are not copy-edited or typeset. Technical support issues aris-
ing from supporting information (other than missing files)
should be addressed to the authors.
TERT SNP and age-related phenotypes, T. Alfred et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
532
